A Phase 3, Randomized, double-blind, multicenter study to EValuate the safety and efficacy of intravenous Iclaprim versus Vancomycin for the trEatment of acute bacterial skin and skin structure infections suspected or confirmed to be due to Gram-pos
about
A Phase 3, Randomized, double-blind, multicenter study to EValuate the safety and efficacy of intravenous Iclaprim versus Vancomycin for the trEatment of acute bacterial skin and skin structure infections suspected or confirmed to be due to Gram-pos
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en-gb
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@nl
type
label
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en-gb
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@nl
prefLabel
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en-gb
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@nl
P2093
P2860
P356
P1154
2-s2.0-85046007587
P1476
A Phase 3, Randomized, double- ...... onfirmed to be due to Gram-pos
@en
P2093
Ali Borghei
Alison McManus
Antoni Torres
David B Huang
Elliot Shin
G Ralph Corey
Matthew Dryden
Patrick McLeroth
Rajesh Shukla
Thomas L Holland
P2860
P356
10.1128/AAC.02580-17
P407
P577
2018-03-12T00:00:00Z